About
This app provides a neuroscience-based nomenclature for psychotropic medications, updating current classifications to reflect modern knowledge. It aims to assist clinicians in making informed prescribing decisions by integrating pharmacology, mode of action, and clinical data.
What's New in NbN C&A
3.1.1
July 6, 2023
- Bug fixes.
User reviews
Developer apps
FAQ
What is NbN C&A?
NbN C&A is a medical reference application that offers a neuroscience-based nomenclature for psychotropic medications. It aims to update current classifications to better reflect contemporary knowledge and assist clinicians in prescribing.
Who developed NbN C&A?
NbN C&A was developed by ECNP Research and Scholarship Stichting (De ECNP Research and Scholarship Foundation).
What information does NbN C&A provide about medications?
NbN C&A provides information on pharmacology, mode of action, approved indications, efficacy and side effects, practical clinical notes, and neurobiology derived from empirical data.
Is NbN C&A available on multiple platforms?
Based on the provided data, NbN C&A is supported on iPhone and iPod devices.
How often is NbN C&A updated?
The application was last updated on July 6, 2023, indicating ongoing development and potential for future updates based on feedback and new findings.
What is the age rating for NbN C&A?
NbN C&A has an age rating of 12+, suggesting it is suitable for users aged 12 and above.
Does NbN C&A have ads?
No, NbN C&A does not contain advertisements. It is a free application without any ad-supported components.
What is the user rating for NbN C&A?
NbN C&A has a user rating of 3.0 stars based on 2 ratings.





